Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 5/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | LDHA | P00338 | 1/20 | 0.34 |
| ▸ | LDHB | P07195 | 1/20 | 0.34 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9960823 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRGAAKDM4ETDP1 | |
| Furan SCHEMBL17140223 | 0.89 | ALDH1A1 (0.39) | ALDH1A1TSHRGAAKDM4ETDP1 | |
| SCHEMBL9946109 | 0.77 | GAA (0.47) | ALDH1A1TSHRGAAKDM4ETDP1 | |
| SCHEMBL31236254 | 0.76 | KDM4E (0.36) | ALDH1A1TSHRGAAKDM4ETDP1 | |
| SCHEMBL51391 | 0.74 | — | — | |
| SCHEMBL18187371 | 0.74 | KDM4E (0.42) | TSHRKDM4ETDP1 | |
| SCHEMBL28571795 | 0.72 | ALDH1A1 (0.54) | ALDH1A1TSHRGAAKDM4ETDP1 | |
| SCHEMBL28562313 | 0.72 | ALDH1A1 (0.54) | ALDH1A1TSHRGAAKDM4ETDP1 | |
| SCHEMBL28565958 | 0.72 | ALDH1A1 (0.54) | ALDH1A1TSHRGAAKDM4ETDP1 | |
| SCHEMBL28576319 | 0.72 | ALDH1A1 (0.54) | ALDH1A1TSHRGAAKDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1063 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| CN-119702022-A | Boron-phosphorus co-doped carbon-based solid acid catalyst with strong adsorptivity, and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2025-03-28 | — | — | CN | claimed |
| CN-118271090-B | Method for improving isostatic graphite and isostatic graphite prepared by same | 湖南德智新材料有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-118344394-A | Near infrared fluorescent probe with large Stokes displacement hydrogen peroxide based on ICT mechanism and preparation method and application thereof | 青岛科技大学 | 2024-07-16 | — | — | CN | claimed |
| CN-118271090-A | Method for improving isostatic graphite and isostatic graphite prepared by same | 湖南德智新材料有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-117946084-A | Linear aza D-A type nonlinear optical material, and preparation method and application thereof | 浙江工业大学 | 2024-04-30 | — | — | CN | claimed |
| US-20230380457-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-30 | — | — | US | claimed |
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| US-20230363426-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-16 | — | — | US | claimed |
| US-20100197915-A1 | LAPATINIB INTERMEDIATES | TEVA PHARMACEUTICALS USA, INC. | 2010-08-05 | — | — | US | claimed |
| WO-2010061400-A1 | A NOVEL PROCESS FOR THE PREPARATION OF LAPATINIB AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | NATCO PHARMA LIMITED (IN) | 2010-06-03 | — | — | WO | claimed |
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | CANADIAN IMPERIAL BANK OF COMMERCE (CA) | 2010-02-18 | — | — | US | claimed |
| WO-2010017387-A2 | LAPATINIB INTERMEDIATES | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2010-02-11 | — | — | WO | claimed |
| EP-2059227-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | Aeris Therapeutics, Inc. (US) | 2009-05-20 | — | — | EP | claimed |
| WO-2008039827-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | AERIS THERAPEUTICS, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| US-7045640-B2 | Method of producing 5-formyl-2-furylboronic acid | DEGUSSA AG (DE) | 2006-05-16 | — | — | US | claimed |
| EP-1403271-B1 | Method of producing 5-formyl-2-furylboronic acid | DEGUSSA (DE) | 2005-11-16 | — | — | EP | claimed |
| US-20040127725-A1 | Method of producing 5-formyl-2-furylboronic acid | DEGUSSA AG (DE) | 2004-07-01 | — | — | US | claimed |
| EP-1403271-A1 | Method of producing 5-formyl-2-furylboronic acid | Degussa AG (DE) | 2004-03-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197915-A1 | LAPATINIB INTERMEDIATES | ERBB2, ABL1, EGFR | ALDH1A1 2645/4885TSHR 1966/4885GAA 1410/4885 |
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | GFER, MUC1, CTH | ALDH1A1 1749/4885TSHR 411/4885GAA 2727/4885 |
| US-20040127725-A1 | Method of producing 5-formyl-2-furylboronic acid | FPR2, FPR1, FPR3 | ALDH1A1 860/4885TSHR 2348/4885GAA 3773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.